- Home
- HIX vs MLAB Comparison
HIX vs MLAB Comparison
Compare HIX & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIX
- MLAB
- Stock Information
- Founded
- HIX 1998
- MLAB 1982
- Country
- HIX United States
- MLAB United States
- Employees
- HIX N/A
- MLAB N/A
- Industry
- HIX Finance/Investors Services
- MLAB Industrial Machinery/Components
- Sector
- HIX Finance
- MLAB Industrials
- Exchange
- HIX Nasdaq
- MLAB Nasdaq
- Market Cap
- HIX 384.6M
- MLAB 341.1M
- IPO Year
- HIX N/A
- MLAB N/A
- Fundamental
- Price
- HIX $4.38
- MLAB $68.98
- Analyst Decision
- HIX
- MLAB Buy
- Analyst Count
- HIX 0
- MLAB 2
- Target Price
- HIX N/A
- MLAB $113.50
- AVG Volume (30 Days)
- HIX 449.5K
- MLAB 195.2K
- Earning Date
- HIX 01-01-0001
- MLAB 11-06-2025
- Dividend Yield
- HIX 13.14%
- MLAB 0.89%
- EPS Growth
- HIX N/A
- MLAB N/A
- EPS
- HIX N/A
- MLAB N/A
- Revenue
- HIX N/A
- MLAB $242,351,000.00
- Revenue This Year
- HIX N/A
- MLAB $5.38
- Revenue Next Year
- HIX N/A
- MLAB $5.25
- P/E Ratio
- HIX N/A
- MLAB N/A
- Revenue Growth
- HIX N/A
- MLAB 8.33
- 52 Week Low
- HIX $4.16
- MLAB $55.45
- 52 Week High
- HIX $5.08
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- HIX 58.49
- MLAB 48.73
- Support Level
- HIX $4.30
- MLAB $63.48
- Resistance Level
- HIX $4.38
- MLAB $75.10
- Average True Range (ATR)
- HIX 0.04
- MLAB 4.09
- MACD
- HIX -0.00
- MLAB 0.81
- Stochastic Oscillator
- HIX 93.75
- MLAB 42.97
About HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.